Presentation is loading. Please wait.

Presentation is loading. Please wait.

Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results.

Similar presentations


Presentation on theme: "Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results."— Presentation transcript:

1 Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results of the randomized trial  Romuald Wojnicz, MD, PhD, Jolanta Nowak, MD, Bożena Szyguła-Jurkiewicz, MD, Krzysztof Wilczek, MD, Andrzej Lekston, MD, PhD, Przemysław Trzeciak, MD, Ewa Nowalany-Kozielska, MD, PhD, Marian Zembala, MD, PhD, Jan Wodniecki, MD, PhD, Lech Poloński, MD, PhD  American Heart Journal  Volume 152, Issue 4, Pages 713.e1-713.e7 (October 2006) DOI: /j.ahj Copyright © 2006 Mosby, Inc. Terms and Conditions

2 Figure 1 Serum NT-proBNP levels at baseline and at 6 and 12 months of follow-ups. Box plots represent from 25th to 75th percentiles with median and individual data. American Heart Journal  , 713.e1-713.e7DOI: ( /j.ahj ) Copyright © 2006 Mosby, Inc. Terms and Conditions

3 Figure 2 Individual patient changes in LV ejection fraction from initial study to follow-up. The asterisk indicates P, between-group comparison at 12-month follow-up. American Heart Journal  , 713.e1-713.e7DOI: ( /j.ahj ) Copyright © 2006 Mosby, Inc. Terms and Conditions


Download ppt "Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results."

Similar presentations


Ads by Google